Sleep apnea study tests pill to boost CPAP use and brain power
NCT ID NCT07332442
First seen Jan 12, 2026 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This study tests whether a sleep medication called eszopiclone can help people with obstructive sleep apnea use their CPAP machine more consistently and improve their thinking skills. About 250 adults with a new sleep apnea diagnosis will receive either eszopiclone or a placebo for three months while using CPAP. Researchers will track how often participants use CPAP and measure changes in attention and daytime sleepiness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Yale Centers for Sleep Medicine
RECRUITINGNorth Haven, Connecticut, 06347, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Eszopiclone (a sleep medication)
What this could lead to
If it works, this could point toward a way to help people with sleep apnea stick with CPAP therapy and possibly improve their thinking and daytime alertness.
What could go wrong
This is a Phase 3 trial, but it's still testing a hypothesis. The sleep aid may not improve CPAP use or thinking, and could cause side effects like drowsiness or dizziness.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.